BioCryst Stock Rises After White House Calls For Quicker Pace On Swine Flu Drugs
Two Phase III trials are planned for a flu antiviral this year, but the company could be asked to provide supplies for U.S. emergency stockpile before approval.
Two Phase III trials are planned for a flu antiviral this year, but the company could be asked to provide supplies for U.S. emergency stockpile before approval.